4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000086
Chief Medical Officer sold 417 shares at $27.55 ($11,488)
- Chief Medical Officer acquired 417 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-05-18 | Option exercise 10b5-1 | +417 | $15.44 | $6,438 | 63,860 | D |
| Rodman David Malcom Chief Medical Officer | 2026-05-18 | Sale 10b5-1 | −417 | $27.55 | $11,488 | 63,443 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-05-18 | Option exercise · Stock Option 10b5-1 | −417 | 4,167 | D | ||
| Open-market sales · 417 sh · avg $27.55 · $11,488 | |||||||
Loading xslF345X06/wk-form4_1779232505.xml…